Express Scripts (ESRX) 76.07 $ESRX
Express Scripts Announces Final Results of Maximum Tender Offers
PR Newswire - Thu Jul 28, 8:15AM CDT
Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts"
today announced the final tender results for its previously announced tender offers (the "Maximum Tender Offers" to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series" that will not result in an aggregate amount that all holders of any such series of Notes are entitled to receive, excluding accrued and unpaid interest, for their Notes of such series that are validly tendered and accepted for purchase in the Maximum Tender Offers exceeding the applicable Aggregate Maximum Tender Amount set forth in the table below. The Maximum Tender Offers were made pursuant to the terms and conditions set forth in the offer to purchase, dated June 29, 2016, as amended by the Company's press releases dated July 14, 2016 announcing the pricing and the early tender results of the Maximum Tender Offers, and the related letter of transmittal (as they may each be amended or supplemented from time to time, the "Tender Offer Documents". The Company refers investors to the Tender Offer Documents for the complete terms and conditions of the Maximum Tender Offers.
ESRX: 76.07 (-1.02)
Top 7 Research Reports for July 27, 2016
Sheraz Mian - Zacks Investment Research - Wed Jul 27, 1:01PM CDT
Top 7 Research Reports for July 27, 2016
RAI: 50.06 (-0.12), SWK: 121.70 (-0.47), ESRX: 76.07 (-1.02), HON: 116.33 (+0.57), CHK: 5.42 (+0.23), TXN: 69.75 (-0.48), VFC: 62.43 (+0.80)
Express Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 10:19AM CDT
Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.
ANTM: 131.34 (-1.56), JNJ: 125.23 (+0.77), ESRX: 76.07 (-1.02), GILD: 79.47 (-1.77)
Express Scripts (ESRX) Tops Q2 Earnings, Lags Revenues
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:55AM CDT
Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.
ANTM: 131.34 (-1.56), JNJ: 125.23 (+0.77), ESRX: 76.07 (-1.02), GILD: 79.47 (-1.77)
Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance
PR Newswire - Mon Jul 25, 3:01PM CDT
Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 second quarter net income of $720.7 million, or $1.13 per diluted share. 2016 second quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.57.1
ESRX: 76.07 (-1.02)
Express Scripts Falls 1.84% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Jul 25, 1:02PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.90 to a high of $78.22. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $78.38 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 76.07 (-1.02)
SmarTrend Watching for Potential Rebound in Shares of Express Scripts After 1.84% Loss
Comtex SmarTrend(R) - Mon Jul 25, 1:00PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.90 to a high of $78.22. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $78.38 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 76.07 (-1.02)
6 GARP Stocks Poised to Yield Healthy Returns
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 7:51AM CDT
When the market is rebounding strongly after bleeding or staying stable over a prolonged time period, investing in stocks by following the GARP strategy should boost one's portfolio returns.
ESRX: 76.07 (-1.02), MCRI: 23.33 (-0.07), TFX: 180.31 (-0.26), WSM: 54.08 (+0.06), WAFD: 25.00 (+0.03), CTXS: 89.13 (+0.07)
Clearent Appoints New Chief Financial Officer
PRWeb - Thu Jul 14, 4:41PM CDT
Today Clearent announced that Chris Knibb has joined the payment processing company as its new Chief Financial Officer (CFO). Knibb joins Clearent from Express Scripts, a Fortune 22 pharmacy benefit management company, where he was Vice President of Financial Planning Analysis. With more than 20 years of financial leadership experience, ranging from a technology start-up to a $100 billion revenue organization, Knibb is well positioned to make an immediate impact at Clearent.
ESRX: 76.07 (-1.02)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 1.02%
Comtex SmarTrend(R) - Thu Jul 14, 12:46PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $78.88 to a high of $80.02. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $79.40 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
SmarTrend Watching for Potential Pullback in Shares of Express Scripts After 1.02% Gain
Comtex SmarTrend(R) - Thu Jul 14, 12:45PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $78.88 to a high of $80.02. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $79.40 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
Express Scripts Holding Company Announces Second Quarter Earnings Conference Call
GlobeNewswire - Mon Jul 11, 4:34PM CDT
Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its second quarter earnings on Monday, July 25, 2016 after the market closes and will hold its quarterly conference call to discuss second quarter results on Tuesday, July 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
ESRX: 76.07 (-1.02)
Halifax Announces Sale of Envision Pharma Group
BusinessWire - Wed Jul 06, 9:01AM CDT
Leading middle-market private equity firm, The Halifax Group ("Halifax", announced today that it has sold Envision Pharma Group ("Envision" to Ardian (the independent private investment company) and GHO Capital (a specialist healthcare investment company), who have partnered with Envision's existing leadership team to purchase the group. Terms of the transaction were not disclosed.
ESRX: 76.07 (-1.02)
Verint Presents New York Life and Express Scripts with 2016 Engage Global Customer Awards
BusinessWire - Wed Jul 06, 7:30AM CDT
--Express Scripts Receives "Highly Commendable" Award Distinction
ESRX: 76.07 (-1.02), VRNT: 35.27 (+0.04)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 23, 10:41PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX) concerning possible violations of federal securities laws between February 24, 2015 and March 21, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline.
ESRX: 76.07 (-1.02)
STOCK ALERT: Rosen Law Firm Reminds Express Scripts Holding Company Investors of Important July 5 Deadline in Class Action - ESRX
GlobeNewswire - Thu Jun 23, 3:04PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the "Class Period" of the important July 5, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws.
ESRX: 76.07 (-1.02)
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:30AM CDT
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
ESRX: 76.07 (-1.02), QRVO: 63.23 (+0.13), OI: 18.79 (+0.06), DISCA: 25.09 (-0.17)
Watch for Express Scripts to Potentially Pullback After Gaining 1.24% Yesterday
Comtex SmarTrend(R) - Wed Jun 22, 12:14PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
Express Scripts Rises 1.24% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 22, 12:13PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
4 Stocks to Buy on Yellen's Valuation Warning
Swarup Gupta - Zacks Investment Research - Wed Jun 22, 9:59AM CDT
This is not the first time that Yellen has weighed in on equities being overvalued.
ESRX: 76.07 (-1.02), QRVO: 63.23 (+0.13), OI: 18.79 (+0.06), DISCA: 25.09 (-0.17)
Express Scripts Announces Final Results of Maximum Tender Offers
PR Newswire - Thu Jul 28, 8:15AM CDT
Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts"
today announced the final tender results for its previously announced tender offers (the "Maximum Tender Offers" to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series" that will not result in an aggregate amount that all holders of any such series of Notes are entitled to receive, excluding accrued and unpaid interest, for their Notes of such series that are validly tendered and accepted for purchase in the Maximum Tender Offers exceeding the applicable Aggregate Maximum Tender Amount set forth in the table below. The Maximum Tender Offers were made pursuant to the terms and conditions set forth in the offer to purchase, dated June 29, 2016, as amended by the Company's press releases dated July 14, 2016 announcing the pricing and the early tender results of the Maximum Tender Offers, and the related letter of transmittal (as they may each be amended or supplemented from time to time, the "Tender Offer Documents". The Company refers investors to the Tender Offer Documents for the complete terms and conditions of the Maximum Tender Offers. ESRX: 76.07 (-1.02)
Top 7 Research Reports for July 27, 2016
Sheraz Mian - Zacks Investment Research - Wed Jul 27, 1:01PM CDT
Top 7 Research Reports for July 27, 2016
RAI: 50.06 (-0.12), SWK: 121.70 (-0.47), ESRX: 76.07 (-1.02), HON: 116.33 (+0.57), CHK: 5.42 (+0.23), TXN: 69.75 (-0.48), VFC: 62.43 (+0.80)
Express Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 10:19AM CDT
Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.
ANTM: 131.34 (-1.56), JNJ: 125.23 (+0.77), ESRX: 76.07 (-1.02), GILD: 79.47 (-1.77)
Express Scripts (ESRX) Tops Q2 Earnings, Lags Revenues
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:55AM CDT
Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.
ANTM: 131.34 (-1.56), JNJ: 125.23 (+0.77), ESRX: 76.07 (-1.02), GILD: 79.47 (-1.77)
Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance
PR Newswire - Mon Jul 25, 3:01PM CDT
Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 second quarter net income of $720.7 million, or $1.13 per diluted share. 2016 second quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.57.1
ESRX: 76.07 (-1.02)
Express Scripts Falls 1.84% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Jul 25, 1:02PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.90 to a high of $78.22. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $78.38 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 76.07 (-1.02)
SmarTrend Watching for Potential Rebound in Shares of Express Scripts After 1.84% Loss
Comtex SmarTrend(R) - Mon Jul 25, 1:00PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.90 to a high of $78.22. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $78.38 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 76.07 (-1.02)
6 GARP Stocks Poised to Yield Healthy Returns
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 7:51AM CDT
When the market is rebounding strongly after bleeding or staying stable over a prolonged time period, investing in stocks by following the GARP strategy should boost one's portfolio returns.
ESRX: 76.07 (-1.02), MCRI: 23.33 (-0.07), TFX: 180.31 (-0.26), WSM: 54.08 (+0.06), WAFD: 25.00 (+0.03), CTXS: 89.13 (+0.07)
Clearent Appoints New Chief Financial Officer
PRWeb - Thu Jul 14, 4:41PM CDT
Today Clearent announced that Chris Knibb has joined the payment processing company as its new Chief Financial Officer (CFO). Knibb joins Clearent from Express Scripts, a Fortune 22 pharmacy benefit management company, where he was Vice President of Financial Planning Analysis. With more than 20 years of financial leadership experience, ranging from a technology start-up to a $100 billion revenue organization, Knibb is well positioned to make an immediate impact at Clearent.
ESRX: 76.07 (-1.02)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 1.02%
Comtex SmarTrend(R) - Thu Jul 14, 12:46PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $78.88 to a high of $80.02. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $79.40 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
SmarTrend Watching for Potential Pullback in Shares of Express Scripts After 1.02% Gain
Comtex SmarTrend(R) - Thu Jul 14, 12:45PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $78.88 to a high of $80.02. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $79.40 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
Express Scripts Holding Company Announces Second Quarter Earnings Conference Call
GlobeNewswire - Mon Jul 11, 4:34PM CDT
Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its second quarter earnings on Monday, July 25, 2016 after the market closes and will hold its quarterly conference call to discuss second quarter results on Tuesday, July 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
ESRX: 76.07 (-1.02)
Halifax Announces Sale of Envision Pharma Group
BusinessWire - Wed Jul 06, 9:01AM CDT
Leading middle-market private equity firm, The Halifax Group ("Halifax"
, announced today that it has sold Envision Pharma Group ("Envision" to Ardian (the independent private investment company) and GHO Capital (a specialist healthcare investment company), who have partnered with Envision's existing leadership team to purchase the group. Terms of the transaction were not disclosed. ESRX: 76.07 (-1.02)
Verint Presents New York Life and Express Scripts with 2016 Engage Global Customer Awards
BusinessWire - Wed Jul 06, 7:30AM CDT
--Express Scripts Receives "Highly Commendable" Award Distinction
ESRX: 76.07 (-1.02), VRNT: 35.27 (+0.04)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 23, 10:41PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company"
(NASDAQ: ESRX) concerning possible violations of federal securities laws between February 24, 2015 and March 21, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline. ESRX: 76.07 (-1.02)
STOCK ALERT: Rosen Law Firm Reminds Express Scripts Holding Company Investors of Important July 5 Deadline in Class Action - ESRX
GlobeNewswire - Thu Jun 23, 3:04PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the "Class Period"
of the important July 5, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws. ESRX: 76.07 (-1.02)
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 8:30AM CDT
The Zacks Analyst Blog Highlights: Owens-Illinois, Discovery Communications, Qorvo and Express Scripts
ESRX: 76.07 (-1.02), QRVO: 63.23 (+0.13), OI: 18.79 (+0.06), DISCA: 25.09 (-0.17)
Watch for Express Scripts to Potentially Pullback After Gaining 1.24% Yesterday
Comtex SmarTrend(R) - Wed Jun 22, 12:14PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
Express Scripts Rises 1.24% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 22, 12:13PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.34 to a high of $76.08. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.25 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 76.07 (-1.02)
4 Stocks to Buy on Yellen's Valuation Warning
Swarup Gupta - Zacks Investment Research - Wed Jun 22, 9:59AM CDT
This is not the first time that Yellen has weighed in on equities being overvalued.
ESRX: 76.07 (-1.02), QRVO: 63.23 (+0.13), OI: 18.79 (+0.06), DISCA: 25.09 (-0.17)
